Drugs in Sport
Drugs in sport
Pharmacology of anabolic steroids
Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement
Erythropoiesis-stimulating agents and other methods to enhance oxygen transport
Growth hormone, IGF-I and insulin and their abuse in sport
Regulation of muscle mass by growth hormone and IGF-I
Gonadotropins in doping
The rush to adrenaline
Indirect androgen doping by oestrogen blockade in sports
Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)
Gene doping
Bone morphogenetic protein signalling is required for the anti-mitogenic effect of the proteasome inhibitor MG-132 on colon cancer cells
Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats
The expression and function of Ca2+-sensing receptors in rat mesenteric artery; comparative studies using a model of type II diabetes
The existence of a local 5-hydroxytryptaminergic system in peripheral arteries
Aldosterone and the autocrine modulation of potassium currents and oxidative stress in the diabetic rat heart
Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk
AM3, a natural glycoconjugate, induces the functional maturation of human dendritic cells
Standard antiepileptic drugs fail to block epileptiform activity in rat organotypic hippocampal slice cultures